GDUFA Research Outcomes
Oligonucleotide APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are oligonucleotides, including antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), and associated impurities in generic products.
-
FDA’s Efforts in Facilitating Generic Oligonucleotide Drug Development
Zhang, Deyi; Yang, Kui; Liang, Likan; Zhang, Li; Kozak, Darby
-
Semi-Validation of the LC-MS/MS Method for Identification and Comparative Quantification of Host Cell Protein (HCP) Impurities in Teriparatide Drug Products
Thawng, Cung; Sommers, Cynthia; Pang, Eric; Keire, David; Zhu, Hongbin
-
Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Ranjbar, Sheyda; O’Reilly Beringhs, Andre; Bin, Qin; Wang, Yan; Lu, Xiuling
-
Validation of HILIC-HRMS Method for Oligonucleotide Analysis
Islam, Md Rabiul; Abdullah, A M; Sommers, Cynthia; Rodriguez, Jason; Zhang, Deyi; Kozak, Darby; Yang, Kui
-
High-Resolution Ion Mobility Mass Spectrometry (IMMS) for Oligonucleotide Impurity Analysis
Dieke, Nnenna; Shipman, Joshua; Sommers, Cynthia; Rodriguez, Jason; Zhang, Deyi; Kozak, Darby; Yang, Kui
-
Validation of HILIC-HRMS Method for Quantitative Oligonucleotide Analysis
Islam, Ad Rabiul; Abdullah, A M; Sommers, Cynthia; Rodriguez, Jason; Zhang, Deyi; Kozak, Darby; Yang, Kui
-
Evaluation of Quantitative Capsule Rupture Test Methods and Data Variability in Generic Omega-3 Capsule Applications
Liu, Hao; Suh, Min Sung; Kozak, Darby; Pang, Eric
-
Scientific Considerations for Synthetic Peptides Referencing Peptide Drugs of rDNA Origin
Hu, Ping; Zhang, Deyi; Kozak, Darby; Jiang, Xiaohui